In this nationwide cohort study of healthcare-managed patients with diabetes surviving an MI, we observe that GLP-1 RAs use in incident MI patients may offer additional cardioprotective benefits over standard of diabetes care. The gene discussed is GLP1R; the disease is diabetes mellitus.